Semaglutide is a GLP-1 receptor agonist that has been studied and approved in some countries for the treatment of type 2 diabetes and obesity. It works by enhancing insulin secretion, slowing gastric emptying, and reducing appetite, which can lead to improved blood sugar control and weight loss.
Disclaimer: When sold as a research chemical, Semaglutide is not approved for human consumption or medical use. It is intended strictly for laboratory research purposes only. Any unauthorized use in humans or animals for therapeutic, diagnostic, or recreational purposes is strictly prohibited. The purchaser assumes full responsibility for proper handling and compliance with all applicable regulations